Close

Biogen (BIIB) shares down 3% following Eli Lilly & Co. (LLY) failure of solanezumab data for Alzheimer's

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/18/2024

1. LVS
2. TSM
3. SPY
4. CSX
5. UAL
6. TSLA
7. ALK
8. EFX
9. ORCL
10. CCI


Go back to Biogen (BIIB) shares down 3% following Eli Lilly & Co. (LLY) failure of solanezumab data for Alzheimer's
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 190.95 -1.21 (0.63%)
Previous Close $192.16    52 Week High $333.65 
Open $191.75    52 Week Low $223.02 
Day High $192.56    P/E 24.45 
Day Low $189.52    EPS $7.81 
Volume 1,007,487